Interaction and functional cooperation between the serine/threonine kinase bone morphogenetic protein type II receptor with the tyrosine kinase stem cell factor receptor

Journal of Cellular Physiology

Volumn 206, Issue 2, 2006, Pages 457-467

  Hassel, Sylke ^a,b   Yakymovych, Mariya ^a   Hellman, Ulf ^a   Rönnstrand, Lars ^c   Knaus, Petra ^b,d   Souchelnytskyi, Serhiy ^a,e  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c LUND UNIVERSITY   (Sweden)

^d FREIE UNIVERSITÄT BERLIN   (Germany)

^e LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 2 RECEPTOR; BONE MORPHOGENETIC PROTEIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; SERINE; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; EUKARYOTE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION;

ANIMALIA; EUKARYOTA;

EID: 30344435306     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20480     Document Type: Article

References (42)

1. Adelman CA, Chattopadhyay S, Bieker JJ. 2002. The BMP/BMPR/Smad pathway directs expression of the erythroid-specific EKLF and GATA1 transcrption factors during embryoid body differentiation in serum-free media. Development 129:539-549.
2. Ashman LK. 1999. The biology of stem cell factor and its receptor c-kit. Int J Biochem Cell Biol 31:1037-1051.
3. Bilbe G, Roberts E, Birch M, Evans DB. 1996. PCR phenotyping of cytokines, growth factors and their receptors and bone matrix proteins in human osteoblast-like cell lines. Bone 19:437-445.
4. Blume-Jensen P, Claesson-Welsh L, Siegbahn A, Zsebo KM, Westermark B, Heldin C-H. 1991. Activation of the human c-kit product by ligand-induced dimerization mediates circular actin reorganization and chemotaxis. EMBO J 10:4121-4128.
5. Blume-Jensen P, Siegbahn A, Stabel S, Heldin C-H, Rönnstrand L. 1993. Increased Kit/SCF receptor induced mitogenicity but abolished cell motility after inhibition of protein kinase C. EMBO J 12:4199-4209.
6. Blume-Jensen P, Rönnstrand L, Gout I, Waterfield M, Heldin C-H. 1994. Modulation of Kit/stem cell factor receptor-induced signaling by protein kinase C. J Biol Chem 269:21793-21802.
7. Broudy VC. 1997. Stem cell factor and haematopoiesis. Blood 90:1345-1364.
8. Detmer K, Walker AN. 2002. Bone morphogenetic proteins act synergistically with haematopoietic cytokines in the differentiation of haematopoietic progenitors. Cytokine 17:36-42.
9. Di Lorenzo G, Autorino R, D'Armiento FP, Mignogna C, De Laurentiis M, De Sio M, D'Armiento M, Damiano R, Vecchio G, De Placido S. 2004. Expression of proto-oncogene c-kit in high risk prostate cancer. Eur J Surg Oncol 30:987-992.
10. Fujii M, Takeda K, Imamura T, Aoki H, Sampath TK, Enomoto S, Kawabata M, Kato M, Ichijo H, Miyazono K. 1999. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol Biol Cell 10:3801-3813.
11. Gallea S, Lallemand F, Atfi A, Rawadi G, Ramez V, Spinella-Jaegle S, Kawai S, Faucheu C, Huet L, Baron R, Roman-Roman S. 2001. Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Bone 28:491-498.
12. Gilboa L, Nohe A, Geissendörfer T, Sebald W, Henis YI, Knaus P. 2000. Bone morphogenetic protein receptor complexes on the surface of live cells: A new oligomerization mode for serine/threonine kinase receptors. Mol Biol Cell 11:1023-1035.
13. Hassel S, Schmitt S, Härtung A, Roth M, Nohe A, Petersen N, Ehrich M, Henis YI, Sebald W, Knaus P. 2003. Initiation of Smad-dependent and Smad-independent signaling via distinct BMP-receptor complexes. J Bone Joint Surgery 85-A:44-51.
14. Hassel S, Eichner A, Yakymovych M, Hellman U, Knaus P, Souchelnytskyi S. 2004. Proteins associated with type II bone morphogenetic protein receptor (BMPR-II) and identified by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 4:1346-1358.
15. Hollnagel A, Oehkmann V, Heymer J, Ruther U, Nordheim A. 1999. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J Biol Chem 274:19838-19845.
16. Kanamoto T, Helman U, Heldin C-H, Souchelnytskyi S. 2002. Functional proteomics of transforming growth factor-beta1-stimulated Mv1Lu epithelial cells: Rad51 as a target of TGF-beta1-dependent regulation of DNA repair. EMBO J 21:1219-1230.
17. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T. 1994. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127:1755-1766.
18. Leevers SJ, Marshall CJ. 1992. Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein. EMBO J 11:569-574.
19. Lin ZH, Han EM, Lee ES, Kim CW, Kim HK, Kim YS. 2004. A distinct expression pattern and point mutation of c-kit in papillary renal cell carcinomas. Mod Pathol 17:611-616.
20. Linnekin D. 1999. Early signaling pathways activated by c-Kit in hematopoietic cells. Int J Biochem Cell Biol 31:1053-1074.
21. Liu F, Ventura F, Doody J, Massague J. 1995. Human type II receptor for bone morphogenetic proteins (BMPs): Extension of the two-kinase receptor model to the BMPs. Mol Cell Biol 15:3479-3486.
22. Lopez-Rovira T, Chalaux E, Massague J, Rosa JL, Ventura F. 2002. Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene. J Biol Chem 277:3176-3185.
23. Lou J, Tu Y, Li S, Manske PR. 2000. Involvement of ERK in BMP2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2. Biochem Biophys Res Commun 268:757-762.
24. Lutz M, Krieglstein K, Schmitt S, ten Dijke P, Sebald W, Wizenmann A, Knaus P. 2004. Nerve growth factor mediates activation of the Smad pathway in PC12 cells. Eur J Biochem 271:920-931.
25. Maeda T, Matsunuma A, Kurahashi I, Yanagawa T, Yoshida H, Horiuchi N. 2004. Induction of osteoblast differentiation induces by statins in MC3T3-E1 cells. J Cell Biochem 92:458-471.
26. Nishimura R, Hata K, Harris SE, Ikeda F, Yoneda T. 2002. Core-binding factor α 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5. Bone 31:303-312.
27. Nishitoh H, Ichijo H, Kimura M, Matsumoto T, Makishima F, Yamaguchi A, Yamashita H, Enomoto S, Miyazono K. 1996. Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5. J Biol Chem 271:21345-21352.
28. Nohe A, Hassel S, Ehrlich M, Neubauer F, Sebald W, Henis YI, Knaus P. 2002. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem 277:5330-5338.
29. Nohe A, Keating E, Knaus P, Petersen NO. 2004. Signal transduction of bone morphogenetic protein receptors. Cell Signal 16:291-299.
30. Okuda K, Sanghera JS, Pelech SL, Kanakura Y, Hallek M, Griffin JD, Druker BJ. 1992. Granulocyte-macrophage colony-stimulating factor, interleukin-3, and steel factor induce rapid tyrosine phosphorylation of p42 and p44 MAP kinase. Blood 79:2880-2887.
31. Otsuka F, Shimasaki S. 2002. A negative feedback system between oocyte bone morphogenetic protein 15 and granuosa cell kit ligand; its role in regulation granulose cell mitosis. Proc Natl Acad Sci USA 99:8060-8065.
32. Paronetto MP, Farini D, Sammarco I, Maturo G, Vespasiani G, Geremia R, Rossi P, Sette C. 2004. Expression of a truncated form of the c-Kit tyrosine kinase receptor and activation of Src kinase in human prostatic cancer. Am J Pathol 164:1243-1251.
33. Persson U, Izumi H, Souchelnytskyi S, Itoh S, Grimsby S, Engström U, Heldin C-H, Funa K, ten Dijke P. 1998. The L45 loop in type I receptors for TGF-beta family members is critical determinant in specifying Smad isoform activation. FEBS Lett 434:83-87.
34. Rosenzweig BL, Imamura T, Okadome T, Cox GN, Yamashita H, ten Dijke P, Heldin C-H, Miyazono K. 1995. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci USA 92:7632-7636.
35. Rudarakanchana N, Flanagan JA, Chen H, Upton PD, Machado R, Patel D, Trembath RC, Morrell NW. 2002. Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension. Hum Mol Genet 11:1517-1525.
36. Rönnstrand L. 2004. Signal transduction via the stem cell factor receptor/c-Kit. Cell Mol Life Sci 61:2535-2548.
37. Sattler M, Salgia R. 2004. Targeting c-Kit mutations: Basic science to novel therapies. Leuk Res 28S1:S11-S20.
38. von Bubnoff A, Cho KWY. 2001. Intracellular BMP signaling regulation in vertebrates: Pathway or network? Dev Biol 239:1-14.
39. Wozney JM. 2002. Overview of bone morphogenetic proteins. Spine 27:S2-SS.
40. Wu H, Klingmuller U, Besmer P, Lodish HF. 1995. Interaction of the erythropoietin and stem-cell-factor receptors. Nature 377:242-246.
41. Yakymovych I, ten Dijke P, Heldin C-H, Souchelnytskyi S. 2001. Regulation of Smad signaling by protein kinase C. FASEB J 15:553-555.
42. Zwijsen A, Verschueren K, Huylebroeck D. 2003. New intracellular components of bone morphogenetic protein/Smad signaling cascades. FEBS Lett 546:133-139.